51 related articles for article (PubMed ID: 16228206)
1. Single protein encapsulated SN38 for tumor-targeting treatment.
Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
[TBL] [Abstract][Full Text] [Related]
3. Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs.
Tseng YH; Lin HP; Lin SY; Chen BM; Vo TNN; Yang SH; Lin YC; Prijovic Z; Czosseck A; Leu YL; Roffler SR
J Control Release; 2024 May; 369():179-198. PubMed ID: 38368947
[TBL] [Abstract][Full Text] [Related]
4. Discovery of
Meng W; Brigance R; Mignone J; Negash L; Zhao G; Ahmad S; Wang W; Moore F; Ye XY; Sun JH; Mathur A; Li YX; Azzara A; Ma Z; Chu CH; Cullen MJ; Rooney S; Harvey S; Kopcho L; Abell L; O'Malley K; Keim W; Dierks EA; Chang S; Foster KA; Harden D; Dabros M; Goti V; De Oliveira C; Krishna G; Pelleymounter MA; Whaley J; Robl JA; Cheng D; Devasthale P
J Med Chem; 2023 Sep; 66(18):13135-13147. PubMed ID: 37724542
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties.
Miller EJ; Mays SG; Baillie MT; Howard RB; Culver DG; Saindane M; Pruett ST; Holt JJ; Menaldino DS; Evers TJ; Reddy GP; Arrendale RF; Natchus MG; Petros JA; Liotta DC
ACS Med Chem Lett; 2016 May; 7(5):537-42. PubMed ID: 27190606
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells.
Wang HY; Nguyen TP; Sternisha AC; Carroll CL; Cross B; Morlock L; Williams NS; McBrayer S; Nijhawan D; De Brabander JK
J Med Chem; 2024 May; ():. PubMed ID: 38804887
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in the Synthesis of Rosettacin.
Tang X; Jiang Y; Song L; Van der Eycken EV
Molecules; 2024 May; 29(10):. PubMed ID: 38792039
[TBL] [Abstract][Full Text] [Related]
8. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents.
Yakkala PA; Penumallu NR; Shafi S; Kamal A
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895927
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 10,11-methylenedioxy-camptothecin glycoside derivatives and investigation of their anti-tumor effects
Wu G; Mai X; Liu F; Lin M; Dong X; Xu Q; Hao C; Zhang L; Yu R; Jiang T
RSC Adv; 2019 Apr; 9(20):11142-11150. PubMed ID: 35520228
[TBL] [Abstract][Full Text] [Related]
10. Cancer therapies utilizing the camptothecins: a review of the in vivo literature.
Venditto VJ; Simanek EE
Mol Pharm; 2010 Apr; 7(2):307-49. PubMed ID: 20108971
[TBL] [Abstract][Full Text] [Related]
11. Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications.
Hartman O; Zhang C; Adams EL; Farach-Carson MC; Petrelli NJ; Chase BD; Rabolt JF
Biomacromolecules; 2009 Aug; 10(8):2019-32. PubMed ID: 19624098
[TBL] [Abstract][Full Text] [Related]
12. Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion.
Kalra AV; Kim J; Klinz SG; Paz N; Cain J; Drummond DC; Nielsen UB; Fitzgerald JB
Cancer Res; 2014 Dec; 74(23):7003-13. PubMed ID: 25273092
[TBL] [Abstract][Full Text] [Related]
13. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin.
Chow DS; Gong L; Wolfe MD; Giovanella BC
Ann N Y Acad Sci; 2000; 922():164-74. PubMed ID: 11193891
[TBL] [Abstract][Full Text] [Related]
14. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Jun; 4(3):152-67. PubMed ID: 11768329
[TBL] [Abstract][Full Text] [Related]
15. [Irinotecan pharmacokinetics].
Chabot GG; Robert J; Lokiec F; Canal P
Bull Cancer; 1998 Dec; Spec No():11-20. PubMed ID: 9932079
[TBL] [Abstract][Full Text] [Related]
16. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC
Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
De Cesare M; Pratesi G; Perego P; Carenini N; Tinelli S; Merlini L; Penco S; Pisano C; Bucci F; Vesci L; Pace S; Capocasa F; Carminati P; Zunino F
Cancer Res; 2001 Oct; 61(19):7189-95. PubMed ID: 11585754
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
